Flucytosine
Showing 1 - 25 of 47
Amphotericin B With Flucytosine-Fluconazole Therapy for
Completed
- Cryptococcal Meningitis
- Amphotericin B 1 mg/kg 1 week & Flucytosine 100 mg/kg 1 week followed by Fluconazole 1200 mg/day 1 week
-
Yangon, MyanmarSpecialist hospital Mingalardon,Thakeyta and Waibargi,Yangon Gen
Apr 20, 2022
Cryptococcal Infection Disseminated Trial in Kisumu, Sindo (Flucytosine and fluconazole, Fluconazole)
Terminated
- Cryptococcal Infection Disseminated
- Flucytosine and fluconazole
- Fluconazole
-
Kisumu, Nyanza, Kenya
- +1 more
Sep 1, 2021
Colorectal Tumors Trial in Lyon, Villejuif, Leeds (TG6002, Flucytosine (5-FC))
Recruiting
- Colorectal Neoplasms
- TG6002
- Flucytosine (5-FC)
-
Lyon, France
- +2 more
Aug 23, 2021
Cryptococcal Meningitis Trial in Beijing (Amphotericin B Colloidal Dispersion, flucytosine, fluconazole)
Not yet recruiting
- Cryptococcal Meningitis
- Amphotericin B Colloidal Dispersion
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,
Completed
- Adult Anaplastic Astrocytoma
- +6 more
- E. coli CD-expressing genetically modified neural stem cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 28, 2021
Colorectal Tumor, Digestive System Tumor Trial in Belgium, France, Spain (TG6002, Flucytosine (5-FC, Ancotil))
Recruiting
- Colorectal Neoplasm
- Digestive System Neoplasm
- TG6002
- Flucytosine (5-FC, Ancotil)
-
Brussels, Belgium
- +6 more
Aug 23, 2021
Meningitis, Cryptococcal, HIV Trial in United States (Itraconazole, Flucytosine, Fluconazole)
Completed
- Meningitis, Cryptococcal
- HIV Infections
- Itraconazole
- +3 more
-
Los Angeles, California
- +23 more
Oct 26, 2021
Advanced Malignant Solid Tumors Trial in Shenyang, Shanghai (T601, T601+5-FC)
Recruiting
- Advanced Malignant Solid Tumors
- T601
- T601+5-FC
-
Shenyang, Liaoning, China
- +1 more
Dec 4, 2020
Meningitis, Cryptococcal, HIV Trial in Puerto Rico, United States (Flucytosine, Fluconazole, Amphotericin B)
Completed
- Meningitis, Cryptococcal
- HIV Infections
- Flucytosine
- +3 more
-
Birmingham, Alabama
- +13 more
Oct 27, 2021
Bladder Cancer Trial (Toca 511, Toca FC (extended-release formulation of flucytosine))
Withdrawn
- Bladder Cancer
- Toca 511
- Toca FC (extended-release formulation of flucytosine)
- (no location specified)
Mar 26, 2020
Anaplastic Astrocytoma, Glioblastoma, Oligodendroglioma Trial (drug, device, other, radiation, procedure, biological)
Withdrawn
- Anaplastic Astrocytoma
- +3 more
- Extended Release Flucytosine
- +7 more
- (no location specified)
Mar 20, 2020
Newly Diagnosed High Grade Glioma (HGG) Trial (Toca 511, Toca FC)
Withdrawn
- Newly Diagnosed High Grade Glioma (HGG)
- Toca 511
- Toca FC
- (no location specified)
Mar 26, 2020
Cryptococcal Meningitis Trial (MAT2203, Amphotericin B)
Not yet recruiting
- Cryptococcal Meningitis
- MAT2203
- Amphotericin B
- (no location specified)
Sep 12, 2022
Glioblastoma Multiforme, Astrocytoma, Gliomas, Malignant Trial in United States (Toca 511 vector, Toca FC • Flucytosine • 5-FC •
Terminated
- Glioblastoma Multiforme
- +2 more
- Toca 511 vector
- Toca FC • Flucytosine • 5-FC • 5-Fluorocytosine
-
Los Angeles, California
- +10 more
Mar 26, 2020
Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer Trial in Denver, Miami, Houston (Toca 511, Toca FC)
Terminated
- Colorectal Cancer
- +11 more
- Toca 511
- Toca FC
-
Denver, Colorado
- +2 more
Feb 5, 2020
Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)
Enrolling by invitation
- Glioblastoma
- +4 more
-
Seongnam, Kyunggido, Korea, Republic ofBundang CHA Medical Center
Jan 6, 2022
Cryptococcosis in Previously Healthy Adults
Recruiting
- Cryptococcus
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Antimicrobial Peptides Against Fungal Infection
Not yet recruiting
- Fungal Infection
- (no location specified)
May 6, 2022
Cryptococcal Meningitis Trial in Kampala (MAT2203, Amphotericin B)
Active, not recruiting
- Cryptococcal Meningitis
- MAT2203
- Amphotericin B
-
Kampala, UgandaInfectious Disease Institute
Nov 16, 2022
Gastrointestinal Cancer Trial in Bonn, Tübingen (TMV-018 + 5-FC, TMV-018 + anti-PD-1, TMV-018 + 5-FC + anti-PD-1)
Withdrawn
- Gastrointestinal Cancer
- TMV-018 + 5-FC
- +2 more
-
Bonn, Germany
- +1 more
Nov 23, 2020
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)
Terminated
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Toca 511
- +4 more
-
Phoenix, Arizona
- +66 more
Feb 6, 2020
Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511 vector, Toca FC)
Completed
- Glioblastoma Multiforme
- +3 more
- Toca 511 vector
- Toca FC
-
Los Angeles, California
- +7 more
May 16, 2018
Cryptococcal Meningitis, HIV Trial in Worldwide (Fluconazole, Amphotericin B)
Completed
- Cryptococcal Meningitis
- HIV Infections
- Fluconazole
- Amphotericin B
-
Los Angeles, California
- +9 more
Nov 2, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511, Toca FC)
Completed
- Glioblastoma Multiforme
- +3 more
- Toca 511
- Toca FC
-
Irvine, California
- +5 more
May 16, 2018